Pharvaris
Logotype for Pharvaris N.V.

Pharvaris (PHVS) investor relations material

Pharvaris Oppenheimer 36th Annual Healthcare Life Sciences Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Pharvaris N.V.
Oppenheimer 36th Annual Healthcare Life Sciences Conference summary26 Feb, 2026

Company background and therapeutic focus

  • Celebrating its 10th anniversary, the company is advancing late-stage development for HAE, a rare genetic disorder causing painful and potentially life-threatening swelling attacks.

  • The main unmet need is for a highly efficacious oral therapy, as most current treatments are injectables.

  • Lead candidate deucrictibant is a B2 receptor antagonist, aiming for broad use in bradykinin-mediated angioedema.

Market landscape and strategy

  • Prophylactic treatment now dominates the HAE market, with about 63% of patients on long-term prophylaxis, representing 80% of market value.

  • Most patients use both on-demand and prophylactic therapies, highlighting the need for comprehensive treatment options.

  • The company aims to differentiate with oral options for both on-demand and prophylactic settings.

Clinical trial results and product differentiation

  • Phase III RAPIDe-3 trial for on-demand use met all primary and secondary endpoints, showing rapid symptom relief (1.28 hours vs. 12 hours for placebo) and early end of progression (17 minutes).

  • 83% of attacks were resolved with a single dose, compared to 59% for a competitor, and the small softgel capsule offers ease of use.

  • The oral formulation is positioned as faster and more convenient than both injectables and other orals.

How will deucrictibant capture on-demand share?
Prophylaxis: How to convert ORLADEYO patients?
What drives confidence in H1 2027 cash runway?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Pharvaris earnings date

Logotype for Pharvaris N.V.
The Citizens Life Sciences Conference 202610 Mar, 2026
Pharvaris
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Pharvaris earnings date

Logotype for Pharvaris N.V.
The Citizens Life Sciences Conference 202610 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Pharvaris N.V. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases, particularly hereditary angioedema (HAE). The company specializes in creating oral bradykinin B2 receptor antagonists, offering alternatives to existing injected treatments. Its key developments include PHVS416, a soft capsule for on-demand use during acute HAE attacks, and PHVS719, an extended-release tablet aimed at preventing such attacks. Pharvaris operates primarily in the Netherlands, Switzerland, and the United States. The company is headquartered in Leiden, the Netherlands, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage